Evidence map›Paper›PMID 18533182›Full record

ArticleJournal of molecular biology2008

Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.

P V Peña, R A Hom, T Hung, H Lin, A J Kuo, R P C Wong, O M Subach, K S Champagne, R Zhao, V V Verkhusha and 3 more

Abstract read
In one paragraph

Article in Journal of molecular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 122 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Structure of a SIN3-HDAC complex from budding yeast.Nature structural & molecular biology · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation.Biochimica et biophysica acta. Gene regulatory mechanisms · 2020
    Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

P V PeñaDepartment of Pharmacology, University of Colorado Health Sciences Center, 12801 East 17th Avenue, Aurora, CO 80045-0511, USA.
R A Hom
T Hung
H Lin
A J Kuo
R P C Wong
O M Subach
K S Champagne
R Zhao
V V Verkhusha
G Li
O Gozani
T G Kutateladze
Stanford University · USUniversity of Colorado Anschutz Medical Campus · USAlbert Einstein College of Medicine · USUniversity of Colorado Health · USUniversity of British Columbia · CAVancouver Coastal Health · CAVancouver Coastal Health Research Institute · CA

Funding

Function of PHD Domain Proteins in Chromatin RegulationR01GM079641 · NIGMS · STANFORD UNIVERSITY · PI GOZANI, OR P. · 2007 to 2020
$4.5M
Molecular Fluorescent ToolkitR01GM073913 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI VERKHUSHA, VLADISLAV · 2006 to 2014
$2.4M
Membrane Targeting by PI-binding DomainsR01GM071424 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2006 to 2009
$1.0M
Structural basis of signaling by ING2 PHDR01CA113472 · NCI · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2006 to 2010
$987k
Kindling Fluorescent Proteins for Tagging and BiosensorsR01GM070358 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI VERKHUSHA, VLADISLAV · 2004 to 2007
$974k
NCI NIH HHS CA113472NCI NIH HHS R01 CA113472NIGMS NIH HHS GM070358NIGMS NIH HHS GM071424NIGMS NIH HHS GM073913NIGMS NIH HHS GM079641NIGMS NIH HHS R01 GM070358NIGMS NIH HHS R01 GM071424NIGMS NIH HHS R01 GM073913NIGMS NIH HHS R01 GM079641
6 · The paper itself

Abstract

Inhibitor of growth 1 (ING1) is implicated in oncogenesis, DNA damage repair, and apoptosis. Mutations within the ING1 gene and altered expression levels of ING1 are found in multiple human cancers. Here, we show that both DNA repair and apoptotic activities of ING1 require the interaction of the C-terminal plant homeodomain (PHD) finger with histone H3 trimethylated at Lys4 (H3K4me3). The ING1 PHD finger recognizes methylated H3K4 but not other histone modifications as revealed by the peptide microarrays. The molecular mechanism of the histone recognition is elucidated based on a 2.1 A-resolution crystal structure of the PHD-H3K4me3 complex. The K4me3 occupies a deep hydrophobic pocket formed by the conserved Y212 and W235 residues that make cation-pi contacts with the trimethylammonium group. Both aromatic residues are essential in the H3K4me3 recognition, as substitution of these residues with Ala disrupts the interaction. Unlike the wild-type ING1, the W235A mutant, overexpressed in the stable clones of melanoma cells or in HT1080 cells, was unable to stimulate DNA repair after UV irradiation or promote DNA-damage-induced apoptosis, indicating that H3K4me3 binding is necessary for these biological functions of ING1. Furthermore, N216S, V218I, and G221V mutations, found in human malignancies, impair the ability of ING1 to associate with H3K4me3 or to induce nucleotide repair and cell death, linking the tumorigenic activity of ING1 with epigenetic regulation. Together, our findings reveal the critical role of the H3K4me3 interaction in mediating cellular responses to genotoxic stresses and offer new insight into the molecular mechanism underlying the tumor suppressive activity of ING1.

Indexed as

DNA RepairApoptosisCrystallography, X-RayHistonesHumansInhibitor of Growth Protein 1Intracellular Signaling Peptides and ProteinsLysineMethylationModels, MolecularMolecular Sequence DataMutationNeoplasmsNuclear ProteinsPeptidesProtein Array AnalysisHistonesING1 protein, humanInhibitor of Growth Protein 1Intracellular Signaling Peptides and ProteinsLysineNuclear ProteinsPeptidesTumor Suppressor Proteins

Identifiers

PMID18533182
PMCPMC2576750
OpenAlexW2024244901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.